不良研究所

Rewriting human health,

one cell at a time

Products | ioCells

Deterministically programmed human iPSC-derived cells for research and drug discovery

Discover ioCells
iocells_vial_radial_0

Cell coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency. 

Explore our platform
bitbio-platform_diagram-horizontal-no_BG-V2.1 bitbio-platform_diagram-vertical-no_BG-min

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

Learn more

Latest news

不良研究所 secures $50 million Series C to scale human cell programming technology News
不良研究所 secures $50 million Series C to scale human cell programming technology 09.01.2026
Published by 不良研究所
Read now
不良研究所 Publishes 2025 Sustainability Report News
不良研究所 Publishes 2025 Sustainability Report 03.12.2025
Published by 不良研究所
Read now
不良研究所 launches Early Access programme for ioHepatocytes, a new iPSC-derived liver model News
不良研究所 launches Early Access programme for ioHepatocytes, a new iPSC-derived liver model 05.11.2025
Published by 不良研究所
Read now
不良研究所 Raises $30 Million Led by M&G Investments Press Release
不良研究所 Raises $30 Million Led by M&G Investments 11.08.2025
Published by 不良研究所
Read now